202 results on '"Seidensticker, Ricarda"'
Search Results
2. Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial
3. Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs
4. Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT
5. Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma
6. In vivo evaluation of tumor uptake and bio-distribution of 99mTc-labeled 1-thio-β-D-glucose and 5-thio-D-glucose in mice model
7. Efficacy and Safety of Local Liver Radioablation in HCC Lesions within and beyond Limits of Thermal Ablation
8. Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
9. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases
10. Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodules
11. Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
12. Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
13. Tolerability of Interstitial Brachytherapy of the Liver: RILD, Imaging, and Laboratory Monitoring
14. Evaluation of tumor uptake and bio-distribution of 99mTc-labeled 1-thio-β-D-glucose and 5-thio-D-glucose in vivo
15. Multi-modal and sequential treatment of liver cancer and its impact on the gastrointestinal tract
16. Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
17. Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy
18. The Impact of Unilateral 90Y-radioembolization on Functional Changes in the Contralateral Hepatic Lobe: The Prospective, Open-label RadioEmbolization, Volumetry, and Liver FuncTion Measurements (REVoluTion) Study
19. Assessing regional hepatic function changes after hypertrophy induction by radioembolisation: comparison of gadoxetic acid-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy.
20. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma.
21. Cholecystitis induced by Yttrium-90 radioembolization of advanced liver tumors: prospective evaluation of a management algorithm in 197 consecutive patients
22. Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
23. Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors: A systematic analysis of 102 cases
24. Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial
25. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma
26. Cytokines and 90Y-Radioembolization: Relation to Liver Function and Overall Survival
27. Additional file 1 of Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs
28. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC)
29. Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma
30. Haemorrhagic Complications and Symptomatic Venous Thromboembolism in Interventional Tumour Ablations: The Impact of Peri-interventional Thrombosis Prophylaxis
31. Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy: Complications and risk factors
32. CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization?
33. Prophylactic Embolization of the Cystic Artery Prior to Radioembolization of Liver Malignancies—An Evaluation of Necessity
34. Radiation-Induced Liver Damage: Correlation of Histopathology with Hepatobiliary Magnetic Resonance Imaging, a Feasibility Study
35. TNF-α Indicates Radiation-induced Liver Injury After Interstitial High Dose-rate Brachytherapy
36. Radioembolisation mit 90Y-markierten Mikrosphären: Posttherapeutische Therapievalidierung mit Bremsstrahlungs-SPECT
37. Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
38. Hepatic Toxicity After Radioembolization of the Liver Using 90Y-Microspheres: Sequential Lobar Versus Whole Liver Approach
39. Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases
40. Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization
41. Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
42. Advantages and Disadvantages of the Amplatzer Vascular Plug IV in Visceral Embolization: Report of 50 Placements
43. Left-Liver Hypertrophy After Therapeutic Right-Liver Radioembolization Is Substantial but Less Than After Portal Vein Embolization
44. Liver Function Changes After Technetium-99m-Macroaggregated Albumin Administration and Their Predictive Value Regarding Hepatotoxicity in Patients Undergoing Yttrium-90-Radioembolization
45. Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas
46. Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
47. Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial
48. Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors
49. Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
50. Gallengangstenosen nach bildgeführter interstitieller Hochdosis-Brachytherapie zentraler und hilusnaher Lebertumore : Eine systematische Analyse von 102 Fällen.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.